Brief: Japan's Aska Pharmaceutical Says U.S. Investment Fund Dalton Investments Notified Company About Possibility For Increasing Stake To Up To About 30%
Aug 18 (Reuters) - ASKA Pharmaceutical Holdings Co Ltd 4886.T: JAPAN'S ASKA PHARMACEUTICAL SAYS U.S. INVESTMENT FUND DALTON INVESTMENTS NOTIFIED COMPANY ABOUT POSSIBILITY FOR INCREASING STAKE TO UP TO ABOUT 30% JAPAN'S ASKA PHARMACEUTICAL: DALTON SAID IT MIGHT NOT BUY UP THE COMPANY STAKES OR SELL THEM DEPENDING ON SITUATION ASKA PHARMACEUTICAL: DALTON SAID IT SHOULD BE OUR MANAGEMENT TO DECIDE WHETHER TO GO PRIVATE Source text: [ID:] Further company coverage: 4886.T (Reporting by Tokyo Newsroom) ((Satoshi.Sugiyama@thomsonreuters.com;))
Recent news on ASKA Pharmaceutical Holdings
See all newsTable: Aska Pharmaceutical Holdings -Q1 group results
Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results